Results 11 to 20 of about 186,102 (296)

Lipid-based nanoparticles as drug delivery carriers for cancer therapy [PDF]

open access: yesFrontiers in Oncology
Cancer is a severe disease that results in death in all countries of the world. A nano-based drug delivery approach is the best alternative, directly targeting cancer tumor cells with improved drug cellular uptake.
Ibtesam Waheed   +7 more
doaj   +2 more sources

Lipid-Based Nanoparticles Fused with Natural Killer Cell Plasma Membrane Proteins for Triple-Negative Breast Cancer Therapy [PDF]

open access: yesPharmaceutics
Immunotherapy combined with chemicals and genetic engineering tools is emerging as a promising strategy to treat triple-negative breast cancer (TNBC), which is more aggressive with poorer progress than other breast cancer subtypes.
Eun-Jeong Won   +4 more
doaj   +2 more sources

Use of Microfluidics to Prepare Lipid-Based Nanocarriers

open access: yesPharmaceutics, 2023
Lipid-based nanoparticles (LBNPs) are an important tool for the delivery of a diverse set of drug cargoes, including small molecules, oligonucleotides, and proteins and peptides. Despite their development over the past several decades, this technology is
Alicia Vogelaar   +4 more
doaj   +1 more source

Immune-Modulating Lipid Nanomaterials for the Delivery of Biopharmaceuticals

open access: yesPharmaceutics, 2023
In recent years, with the approval of preventative vaccines for pandemics, lipid nanoparticles have become a prominent RNA delivery vehicle. The lack of long-lasting effects of non-viral vectors is an advantage for infectious disease vaccines.
Songhee Kim   +3 more
doaj   +1 more source

From Bench to Bedside: Implications of Lipid Nanoparticle Carrier Reactogenicity for Advancing Nucleic Acid Therapeutics

open access: yesPharmaceuticals, 2023
In biomedical applications, nanomaterial-based delivery vehicles, such as lipid nanoparticles, have emerged as promising instruments for improving the solubility, stability, and encapsulation of various payloads.
Tetiana Korzun   +7 more
doaj   +1 more source

Surface Modification of Lipid-Based Nanoparticles

open access: yesACS Nano, 2022
There is a growing interest in the development of lipid-based nanocarriers for multiple purposes, including the recent increase of these nanocarriers as vaccine components during the COVID-19 pandemic. The number of studies that involve the surface modification of nanocarriers to improve their performance (increase the delivery of a therapeutic to its ...
Yining Xu   +5 more
openaire   +3 more sources

Lipid-based nanoparticle production in Micromixers [PDF]

open access: yesProceedings of Micromachines 2021 — 1st International Conference on Micromachines and Applications (ICMA2021), 2021
Lipid-based nanoparticles have demonstrated to be a versatile vehicle for drugs, genetic material, and labels. These particles are often made of biocompatible and biodegradable materials, enabling a safe interaction with biological systems. The importance of this type of delivery vehicle has been shown recently, as the two leading vaccines are based on
Vahé Nerguizian, Rodrigo Lopez Salazar
openaire   +1 more source

Preclinical Evaluation of Lipid-Based Nanosystems

open access: yesPharmaceutics, 2021
The use of lipid-based nanosystems, including lipid nanoparticles (solid lipid nanoparticles—SLN, and nanostructured lipid carriers—NLC), nanoemulsions, and liposomes, among others, is widespread [...]
Ana Catarina Silva   +1 more
doaj   +1 more source

Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy

open access: yesPharmaceutics, 2023
Nanotechnology takes the lead in providing new therapeutic options for cancer patients. In the last decades, lipid-based nanoparticles—solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), liposomes, and lipid–polymer hybrid ...
Ana Camila Marques   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy